Genestra Brands Liv Complex
Natural health product licensed in Canada
- Other names
- Genestra Brands Liver Support Complex
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80039962
- Status
- Active licence
- Licence date
- 14 February 2013
- Revision date
- 31 July 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bupleurum chinense Source : Racine Extract : Extract Type TBA Extraction ratio : 4:1 Dry plant equivalent : 240 mg | Not specified | Not calculated |
| Bupleurum chinense Source : Racine | 60 mg | Not calculated |
| Cynara cardunculus Source : Feuille Extract : Extract Type TBA Extraction ratio : 4:1 Dry plant equivalent : 700 mg | Not specified | Not calculated |
| Cynara cardunculus Source : Feuille | 175 mg | Not calculated |
| Chionanthus virginicus Source : Écorce Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 120 mg | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help to support liver function, increase bile flow and relieve digestive disturbances.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity is known to occur, in which case, discontinue use.
- Précautions et mises en garde
If symptoms persist or worsen, consult your healthcare practitioner. Discontinue use if you develop symptoms of liver trouble. Bupleurum can cause sedation; use caution when taking other sedatives and operating vehicle or hazardous machinery.
- Contre-indications
If you are pregnant or breastfeeding; or if you have a bowel or bile duct obstruction, gallstones, liver or gall bladder disorders; or if you are allergic to the Asteraceae/Compositae/Daisy family, do not use.
Source
Official Health Canada record, licence 80039962
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging